Remote Ischemic Conditioning for PwSCI
Remote Ischemic Conditioning Intervention to Enhance the Cardiometabolic Health of Persons With SCI
2 other identifiers
interventional
24
1 country
1
Brief Summary
The long-term goal of this project is to improve the overall cardiometabolic health of persons with spinal cord injury (SCI). This pilot study will test the feasibility and acceptability of remote ischemic conditioning implemented in a home setting by persons with SCI and collect cardiometabolic health outcomes to inform appropriate outcomes for a future larger trial. Researchers will compare, RIC high dose using standard blood pressure cuff to RIC high dose using automated blood flow restriction cuff to RIC low dose using standard blood pressure cuff, to determine cardiometabolic health improvements amongst groups. Participants will: Complete an initial 2-day assessment, participate in a 6-week intervention using remote ischemic conditioning (RIC) within their home, complete a 2-day post assessment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 23, 2026
CompletedFirst Submitted
Initial submission to the registry
March 10, 2026
CompletedFirst Posted
Study publicly available on registry
March 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 30, 2027
March 23, 2026
March 1, 2026
1.4 years
March 10, 2026
March 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Brachial artery diameter change (cm)
Participants will undergo a Brachial Artery Reactivity Test (BART) via upper arm doppler ultrasound. The test will measure flow-mediated dilation and endothelium independent dilation of the brachial artery using a high-resolution transducer on the Vivid E95, E9, Vivid IQ (portable) or Vivid I (portable) systems. Brachial artery flow-mediated vasodilation correlates with measures of coronary artery endothelial function and can predict future adverse coronary events. Results will be reported as brachial artery diameter change between baseline and 30 seconds into test, unit of measure is cm.
Baseline and up to 2 weeks post intervention
Arterial stiffness - Pulse wave velocity (PWV)
This test is a non-invasive cardiovascular assessment that measures arterial stiffness. Arterial stiffness will be obtained by measuring carotid-femoral pulse wave velocity using the SphygmoCor XCEL system.
Baseline and up to 2 weeks post intervention
Secondary Outcomes (4)
Inflammation change - High sensitivity C reactive protein - hsCRP - (mg/L, reported as % change)
Baseline and up to 2-weeks post intervention
Immune system activation/response change - Interleukin 6 - IL-6 - (pg/mL, reported as % change)
Baseline and up to 2-weeks post intervention
Low density lipoprotein cholesterol (LDL) change - (mg/dL, reported as % change)
Baseline and up to 2-weeks post intervention
High-density lipoprotein cholesterol (HDL) change - (mg/dL, reported as % change)
Baseline and up to 2-weeks post intervention
Study Arms (3)
Remote ischemic conditions (RIC) high-dose using standard blood pressure cuff
ACTIVE COMPARATORA group provided 6-weeks of remote ischemic conditioning (RIC) intervention within their home. 5 days a week the participant will complete 1 session of 4 cycles of inflating/deflating a standard blood pressure cuff to 20 mmHg higher than their measured systolic blood pressure on an arm. The participant will also complete a daily log of their RIC sessions.
Remote ischemic conditioning (RIC) high-dose using the automated blood flow restriction cuff
ACTIVE COMPARATORA group provided 6-weeks of remote ischemic conditioning (RIC) intervention within their home. 5 days a week the participant will complete 1 session of 4 cycles of inflation/deflation of an automated blood flow restriction cuff to 20 mmHg higher than their measured systolic blood pressure on an arm. The participant will also complete a daily log of their RIC sessions.
Remote ischemic conditioning (RIC) low-dose using standard blood pressure cuff
PLACEBO COMPARATORA group provided 6-weeks of remote ischemic conditioning (RIC) intervention within their home. 5 days a week the participant will complete 1 session of 4 cycles of inflating/deflating a blood pressure cuff to 10 mmHg below their measured diastolic blood pressure on an arm. The participant will also complete a daily log of their RIC sessions.
Interventions
The RIC high-dose using a standard blood pressure cuff group will participate in 6-weeks of self or support-person applied/assisted remote ischemic conditioning (RIC) intervention within their home. 5 days a week the participants will complete 1 session of 4 cycles of inflating/deflating a standard blood pressure cuff to 20 mmHg higher than their measured systolic blood pressure on an arm. The blood pressure cuff will be inflated and held for 5 minutes, then deflated (released) for 5 minutes and this will be repeated a total of 4 cycles. This process will take about 35 minutes to complete each day. The participants will also complete a daily log of their RIC sessions. The overall goal is to improve cardiometabolic health of persons with spinal cord injury.
The RIC high-dose automated blood flow restriction cuff group will participate in 6-weeks of self or support-person applied/assisted remote ischemic conditioning (RIC) intervention within their home. 5 days a week the participants will complete 1 session of 4 cycles of inflation/deflation of an automated blood flow restriction cuff to 20 mmHg higher than their measured systolic blood pressure on an arm. The restriction cuff will inflate and hold for 5 minutes, then deflate (release) for 5 minutes and this will be repeated a total of 4 cycles. This process will take about 35 minutes to complete each day. The participants will also complete a daily log of their RIC sessions. The overall goal is to improve the cardiometabolic health of persons with spinal cord injury.
The RIC low-dose standard blood pressure cuff group will participate in 6-weeks of self or support-person applied/assisted remote ischemic conditioning (RIC) intervention within their home. 5 days a week the participants will complete 1 session of 4 cycles of inflating/deflating a blood pressure cuff to 10 mmHg below their measured diastolic blood pressure on an arm. The blood pressure cuff will be inflated and held for 5 minutes, then deflated (released) for 5 minutes and this will be repeated a total of 4 cycles. This process will take about 35 minutes to complete each day. The participants will also complete a daily log of their RIC sessions.
Eligibility Criteria
You may qualify if:
- years of age or older
- Diagnosis of SCI
- Live within the community (not nursing facility)
- Not actively engaged in physical activity for exercise
- Not having the ability to participate in physical activity due to physical capacity or environmental barriers
- Medically stable
- Ability to obtain physician approval to participate in the study
- Willingness to participate in a 2-day initial assessment visit at research testing location, 30 intervention sessions conducted independently by the participant or caregivers, 2-day post intervention assessment visit at research testing location.
You may not qualify if:
- Medically unstable
- Have had a heart-related condition within the past year
- Have had a blood clot in the past year
- Have a stage 3 or 4 pressure injury
- Have taken blood thinners in the past year
- Have had surgery in the past year
- Have uncontrolled hypertension
- Have peripheral artery disease
- Have Complex Regional Pain Syndrome (CRPS) in both arms
- Have had nerve or tendon transfers in the arms in the past year
- Have lymphedema in the arms
- Have recent acute illness or injury (within the past 3 months)
- Currently pregnant
- Enrolled in another clinical trial
- Are taking GLP-1 medications
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Washington University School of Medicine
St Louis, Missouri, 63108, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kerri A Morgan, PhD
Washington University School of Medicine - Program in Occupational Therapy
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Occupational Therapy and Neurology, Director, Research Division of Occupational Therapy
Study Record Dates
First Submitted
March 10, 2026
First Posted
March 23, 2026
Study Start
February 23, 2026
Primary Completion (Estimated)
July 30, 2027
Study Completion (Estimated)
July 30, 2027
Last Updated
March 23, 2026
Record last verified: 2026-03